TS-172 Hyperphosphatemia Hemodialysis Phase 3 Study
Summary
A Phase 3 clinical trial (NCT07548840) is registered on ClinicalTrials.gov evaluating TS-172 for treatment of hyperphosphatemia in patients undergoing hemodialysis. The study is categorized under Phase 3 interventional trials sorted by start date.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
A new Phase 3 clinical trial has been registered with ClinicalTrials.gov under identifier NCT07548840. The study will evaluate TS-172 as a treatment for hyperphosphatemia in patients receiving hemodialysis. This registry entry provides publicly accessible information about the trial's scope and classification.
Pharmaceutical companies sponsoring or conducting late-stage renal or metabolic drug trials should monitor ClinicalTrials.gov for competitive landscape awareness regarding hyperphosphatemia treatments in the hemodialysis population.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.